Surgery is often the first step in treating kidney cancer, and new data questions whether removing only the tumor is better than removing the entire kidney.
Using robotic ultrasound probes for identification of kidney tumors during robotic partial nephrectomy offered the advantage of surgeon autonomy compared with the use of laparoscopic ultrasound probes.
Adjuvant imatinib impacts short-term free from relapse in patients with localized, surgically resected, high/intermediate-risk gastrointestinal stromal tumors (GIST), according to interim results of an intergroup trial.
Additional therapy may be needed for patients with advanced bladder cancers that are surgically removed. A five-year, international study validated the use of a marker panel to predict which patients are more likely to have a recurrence of cancer after bladder removal.
Placing a stent within the aorta facilitated the subsequent removal of a tumor in the aorta and eliminated the need for heart-lung bypass for research patients.
A breast cancer assay helped quantify the risk of recurrence after surgical excision for ductal carcinoma in situ (DCIS) without radiation.
The imaging technique of DTI allows neurosurgeons to visualize important pathways in the brain. This allows them to better adapt brain tumor surgeries and preserve language, visual function, and motor function while removing cancerous tissue.
Despite the low risk of lymphedema after sentinel lymph node biopsy, most women worry about this complication and practice risk-reducing behaviors to avoid it.